Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 9:2020:1418978.
doi: 10.1155/2020/1418978. eCollection 2020.

A Nomogram Based on Clinicopathologic Features and Preoperative Hematology Parameters to Predict Occult Peritoneal Metastasis of Gastric Cancer: A Single-Center Retrospective Study

Affiliations

A Nomogram Based on Clinicopathologic Features and Preoperative Hematology Parameters to Predict Occult Peritoneal Metastasis of Gastric Cancer: A Single-Center Retrospective Study

Chao Yang et al. Dis Markers. .

Abstract

Background: In patients with gastric cancer (GC), peritoneal metastasis is an indication of the end stage and often indicates a poor outcome. The diagnosis of peritoneal metastasis, especially occult peritoneal metastasis (OPM), remains a challenge for surgeons. This study was designed to explore the relationship between OPM and clinicopathological characteristics and preoperative hematological parameters in patients with GC and to develop a nomogram to predict the probability of OPM before surgery.

Methods: A total of 672 patients with GC from our center were included, including 583 OPM-negative and 89 OPM-positive patients. These patients were divided into training and validation groups based on when they received treatment. OPM was diagnosed during surgery in patients without any signs of metastasis through imaging examination. Predictive factors were screened by least absolute shrinkage and selection operator logistic regression of all 18 characteristics. The nomogram of OPM was constructed based on these filtered variables. The discriminative and calibration performance of the model were simultaneously evaluated.

Results: A total of six variables, including tumor size, degree of differentiation, depth of invasion, Glasgow prognosis score, and plasma levels of CA125 and fibrinogen, were selected for integration into the final predictive nomogram. The area under curve (AUC) of the nomogram with six factors was 0.906 (95% confidence interval (CI): 0.872-0.941) and 0.889 (95% CI: 0.795-0.984) in the training and validation groups, respectively. Calibration plots of the nomogram in the two sets revealed a good consistency between predicted and actual probabilities. Decision curve analysis showed that the nomogram had a positive net benefit among all threshold probabilities between 0% and 82%. This nomogram was superior to models incorporating only clinicopathologic or hematologic features.

Conclusion: Both clinicopathological and preoperative hematological parameters are significantly associated with OPM. The nomogram constructed with six factors could be used to calculate the probability of OPM and identify the high-risk population in GC. This may be helpful for early detection of OPM in patients with GC.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Predictive features were selected using the LASSO binary logistic regression model. (a) LASSO coefficient of the 18 OPM-associated predictors. (b) Feature selection using the LASSO model and 10-fold cross-validation via minimum criteria. The model had excellent performance and the least number of independent variables when lambda was -3.082.
Figure 2
Figure 2
Nomogram for the probability of OPM based on the six predictors: tumor size, degree of differentiation, depth of invasion, GPS, and plasma levels of CA125 and fibrinogen. OPM: occult peritoneal metastasis; CA125: carbohydrate antigen 125; GPS: Glasgow prognosis score; FIB: fibrinogen.
Figure 3
Figure 3
The discriminative abilities of Models A, B, and C were evaluated using the AUC of ROCs. Model A (including clinicopathological and preoperative hematological parameters) had the best performance both in the training (a) and validation (b) cohorts (DeLong's test, P < 0.05).
Figure 4
Figure 4
Nomogram calibration plots. (a) Calibration plot of the nomogram in the training set showed that the predicted and actual probabilities were similar. (b) In the validation cohort, the nomogram calibration plot revealed the consistency of the model (both Hosmer-Lemeshow's test, P > 0.05).
Figure 5
Figure 5
The net benefit curves for the three nomogram models in the training group. Model A had a positive net benefit when thresholds were between 0 and 82%.

Similar articles

Cited by

References

    1. Bray F., Ferlay J., Soerjomataram I., Siegel R. L., Torre L. A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68(6):394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Nakayama I., Chin K., Matsushima T., et al. Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis. International Journal of Clinical Oncology. 2017;22(6):1060–1068. doi: 10.1007/s10147-017-1164-4. - DOI - PubMed
    1. Kim S. J., Kim H. H., Kim Y. H., et al. Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer. Radiology. 2009;253(2):407–415. doi: 10.1148/radiol.2532082272. - DOI - PubMed
    1. Burbidge S., Mahady K., Naik K. The role of CT and staging laparoscopy in the staging of gastric cancer. Clinical Radiology. 2013;68(3):251–255. doi: 10.1016/j.crad.2012.07.015. - DOI - PubMed
    1. Wu X., Li Z., Li Z., et al. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis. Journal of Surgical Oncology. 2015;111(7):840–847. doi: 10.1002/jso.23889. - DOI - PubMed